Filters

Drugs

Showing results (6901-6910 of 7,133) with videos related to

Pageof 714
Sort By:
Drugs|November 22, 2005
Issues for clinical drug development in neurodegenerative diseasesMichel Dib
Drugs|November 22, 2005
Parathyroid hormone as an anabolic skeletal therapyMishaela R Rubin, John P Bilezikian
Drugs|July 1, 1997
Primary prevention of coronary heart disease. What has WOSCOPS told us and what questions remain? West Of Scotland Coronary Prevention StudyV Maher, J Sinfuego, P Chao, et al.
Drugs|July 1, 1997
Trends and future developments in the pharmacological treatment of acute ischaemic strokeG J del Zoppo, S Wagner, M Tagaya
Drugs|July 1, 1997
Recognition and management of bacterial arthritisM A Cimmino
Drugs|July 1, 1997
The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infectionsG W Amsden, C A Peloquin, S E Berning
Drugs|July 1, 1997
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropeniaL R Wiseman, H M Lamb
Drugs|December 13, 2005
A pharmacological approach to gastric acid inhibitionJuan V Esplugues
Drugs|December 13, 2005
What is potent acid inhibition, and how can it be achieved?Xavier Calvet, Fernando Gomollón
Drugs|December 13, 2005
Diagnostic value of potent acid inhibition in gastro-oesophageal reflux diseaseJoan Monés
Pageof 714

Showing results (6901-6910 of 7,133) with videos related to

Sort By:
Pageof 714
Drugs|November 22, 2005
Issues for clinical drug development in neurodegenerative diseasesMichel Dib
Drugs|November 22, 2005
Parathyroid hormone as an anabolic skeletal therapyMishaela R Rubin, John P Bilezikian
Drugs|July 1, 1997
Primary prevention of coronary heart disease. What has WOSCOPS told us and what questions remain? West Of Scotland Coronary Prevention StudyV Maher, J Sinfuego, P Chao, et al.
Drugs|July 1, 1997
Trends and future developments in the pharmacological treatment of acute ischaemic strokeG J del Zoppo, S Wagner, M Tagaya
Drugs|July 1, 1997
Recognition and management of bacterial arthritisM A Cimmino
Drugs|July 1, 1997
The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infectionsG W Amsden, C A Peloquin, S E Berning
Drugs|July 1, 1997
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropeniaL R Wiseman, H M Lamb
Drugs|December 13, 2005
A pharmacological approach to gastric acid inhibitionJuan V Esplugues
Drugs|December 13, 2005
What is potent acid inhibition, and how can it be achieved?Xavier Calvet, Fernando Gomollón
Drugs|December 13, 2005
Diagnostic value of potent acid inhibition in gastro-oesophageal reflux diseaseJoan Monés
Pageof 714
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us